Key result
High insulin resistance linked to decreased endothelial function in nondiabetic predialysis CKD.
Why the study?
The association of insulin resistance and inflammation with vascular disease in nondiabetic predialysis CKD patients was unknown.
Case-Control (n=70)
In nondiabetic predialysis CKD patients, insulin resistance and systemic inflammation are independently associated with endothelial dysfunction and atherosclerosis.
Answers are grounded in this paper and cite their sources.
IR and inflammation independently associated with vascular dysfunction in nondiabetic predialysis CKD; hypothesis-generating, needs prospective confirmation before clinical implications.
BACKGROUND: Chronic kidney disease (CKD) is associated with high cardiovascular morbidity and mortality, which is not fully explained by traditional risk factors; hence, the interest in nontraditional risk factors such as inflammation and insulin resistance (IR). Though IR is shown in nondiabetic CKD, its association with vascular disease and inflammation in this population is unknown, and is what this study aims to investigate. HYPOTHESIS: IR and inflammation are related to vascular disease in nondiabetic predialysis CKD patients. METHODS: We studied carotid-artery intima-media thickness (IMT) and endothelial function (brachial artery flow mediated dilation [FMD]) in 35 nondiabetic predialysis patients with stage 3-5 CKD and 35 age- and gender-matched controls. Insulin resistance was measured using the homeostasis model assessment for insulin resistance score (HOMA-IR), inflammation by high-sensitivity CRP (hsCRP), and their relationship with FMD and IMT. RESULTS: Patients with CKD showed reduced FMD (3.34 ± 2.14% vs. 5.27 ± 1.78%, P<0.001) and increased IMT (0.78 ± 0.22 mm vs. 0.64 ± 0.16 mm, P = 0.003) compared with controls. The CKD patients had a higher HOMA-IR (2.20 ± 1.08 vs. 1.13 ± 0.64, P<0.001) and hsCRP (3.25 ± 5.47 mg/L vs. 1.10 ± 1.85 mg/L [median ± interquartile range], P = 0.02). In the study population, HOMA-IR was directly related to hsCRP. After adjusting for traditional risk factors, high HOMA-IR and hsCRP were significantly related to decreased FMD (adjusted β = -0.44, 95% confidence interval [CI]: -1.55 to -0.08, P = 0.003 and adjusted β = -0.51, 95% CI: -0.51 to -0.15, P = 0.001) and increased IMT (adjusted β = 0.62, 95% CI: 0.54-1.90, P = 0.001 and adjusted β = 0.43, 95% CI: 0.08-0.57, P = 0.011), respectively. CONCLUSIONS: Subjects with systemic inflammation were more insulin-resistant, and in nondiabetic predialysis CKD, IR and systemic inflammation were independently associated with endothelial dysfunction and atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Banerjee et al. (2011) conducted a case-control in Nondiabetic predialysis chronic kidney disease (n=70). Insulin resistance (HOMA-IR) and systemic inflammation (hsCRP) vs. Lower levels of insulin resistance and inflammation was evaluated on Decreased brachial artery flow mediated dilation (FMD) (adjusted β -0.44, 95% CI -1.55 to -0.08, p=0.003). In nondiabetic predialysis CKD, high insulin resistance was independently associated with decreased endothelial function.
Synapse has enriched 10 related papers. Consider them for comparative context: